The study entitled "Effects of Reducose on Postprandial Glycemic Peak in Obese Children and Adolescents: A Pilot Study" aims to evaluate the improvement in glycemic and insulinemic levels produced by Reducose, a food supplement extracted from white mulberry (Morus alba), after 12 weeks of treatment in a cohort of obese children and adolescents. Clinical and anthropometric data (age, sex, weight, height, BMI, pubertal stage) will be collected, along with data from blood chemistry tests performed during routine follow-up visits, in accordance with Good Clinical Practice guidelines.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Area Under the Curve for Plasma Glucose
Timeframe: Baseline and Week 12
Area under the curve (AUC) for plasma insulin
Timeframe: Baseline and Week 12
Maximum plasma glucose concentration (Gmax)
Timeframe: Baseline and Week 12
Time to maximum plasma glucose concentration (Tmax)
Timeframe: Baseline and Week 12
Glycated Hemoglobin
Timeframe: Change in glycated hemoglobin from baseline to Week 12, measured in fasting blood samples.
Homeostasis Model Assessment of Insulin Resistance
Timeframe: Baseline to Week 12